Skip to main content

Want a detailed portfolio tracker?

Immunocore (IMCR) P/E (2023 - 2026)

Immunocore (IMCR) P/E from Mar 31, 2023 to Jul 20, 2026. The TTM Immunocore (IMCR) P/E is -62.37. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immunocore (IMCR)

YearP/EChange
2026-62.37+25.97%
2025-49.51+71.38%
2024-28.89-68.94%
2023-93.02N/A

Comparison Immunocore (IMCR) P/E with competitors

Immunocore (IMCR) P/E is -62.37.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.12%
FGENFibroGen Inc0.24-100.38%
CHRSCoherus Biosciences Inc0.85-101.36%
FBIOFortress Biotech Inc0.95-101.52%
ORMPOramed Pharmaceuticals Inc1.50-102.41%
AGENAgenus Inc3.01-104.83%
INVAInnoviva Inc3.15-105.06%
VXRTVaxart Inc3.55-105.69%
CRMDCorMedix Inc3.63-105.82%
CVACCureVac N.V.4.45-107.13%
GLPGGalapagos NV4.86-107.79%
SRPTSarepta Therapeutics Inc4.88-107.83%
ABEOAbeona Therapeutics Inc5.39-108.64%
ABUSArbutus Biopharma Corp5.60-108.97%
ZVRAZevra Therapeutics Inc5.89-109.44%
SPROSpero Therapeutics Inc6.23-109.99%
CGENCompugen Ltd6.31-110.12%
RIGLRigel Pharmaceuticals6.87-111.02%
SLXNSilexion Therapeutics Corp7.30-111.70%
OMEROmeros Corporation9.26-114.84%
AUPHAurinia Pharmaceuticals Inc9.58-115.37%
PLXProtalix BioTherapeutics Inc10.89-117.46%
ACADAcadia Pharmaceuticals Inc11.73-118.80%
TBPHTheravance Biopharma Inc12.26-119.66%
ADMAAdma Biologics Inc12.42-119.91%
HRMYHarmony Biosciences Holdings Inc13.82-122.16%
SABSSAB Biotherapeutics Inc14.14-122.66%
NAGENiagen Bioscience Inc14.82-123.76%
INCYIncyte Corp15.82-125.37%
REGNRegeneron Pharmaceuticals Inc15.86-125.42%
PBYIPuma Biotechnology Inc17.32-127.76%
CPRXCatalyst Pharmaceuticals Inc17.44-127.96%
EXELExelixis Inc17.54-128.12%
TGTXTG Therapeutics Inc18.97-130.41%
MDXGMimedx Group Inc20.55-132.95%
XOMAXOMA Royalty Corp22.87-136.67%
ARGXArgen X SE24.30-138.96%
CTMXCytomX Therapeutics Inc24.82-139.79%
XOMAOXOMA Royalty Corp25.34-140.63%
HALOHalozyme Therapeutics Inc25.62-141.08%
XOMAPXOMA Royalty Corp25.67-141.16%
VRTXVertex Pharmaceuticals Inc27.99-144.88%
RPRXRoyalty Pharma plc - Class A28.69-145.99%
SLNOSoleno Therapeutics Inc29.02-146.52%
ASNDAscendis Pharma A/S30.09-148.24%
LGNDLigand Pharmaceuticals Inc - Class B37.91-160.78%
APLSApellis Pharmaceuticals Inc39.02-162.56%
BMRNBiomarin Pharmaceutical Inc42.21-167.68%
KRYSKrystal Biotech Inc45.34-172.70%
ONCBeiGene Ltd69.54-211.49%
PHARPharming Group N.V.75.03-220.29%
TECHBio-Techne Corp101.96-263.47%
VCELVericel Corp109.92-276.23%
ALNYAlnylam Pharmaceuticals Inc117.96-289.13%
GMABGenmab140.29-324.92%
TLXTelix Pharmaceuticals Ltd162.15-359.97%
CORTCorcept Therapeutics Inc212.86-441.27%